Erythrocyte glutathione and tumour response to chemotherapy
- 2 May 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 339 (8801) , 1074-1076
- https://doi.org/10.1016/0140-6736(92)90664-o
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2αBritish Journal of Cancer, 1991
- The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycinCancer Treatment Reviews, 1990
- Role of glutathione in the radiation response of mammalian cells invitro and in vivoPharmacology & Therapeutics, 1990
- Keynote address: Glutathione modulation in cancer treatment: Will it work?International Journal of Radiation Oncology*Biology*Physics, 1989
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- Riboflavin Metabolism in the Hypothyroid Human AdultExperimental Biology and Medicine, 1987
- Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- [74] Methods for the selective modification of glutathione metabolism and study of glutathione transportPublished by Elsevier ,1985
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Thyroid hormone control of glutathione reductase activity in rat erythrocytes and liverAmerican Journal of Physiology-Legacy Content, 1974